Victor Romo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Victor Romo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Pascal Jabbour
Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
3 shared publications - Stavropoula Tjoumakaris
Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
3 shared publications David Wyler
Department of Anesthesiology, Division of Neurological Anesthesia, Thomas Jefferson University Hospital, Philadelphia, PA, USA, 19107
2 shared publications- Hekmat Zarzour
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
2 shared publications - Michael Reid Gooch
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
2 shared publications - Nikolaos Mouchtouris
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, United States
2 shared publications
Latest Publications
- 21 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Incidence and Predictors of Hemorrhagic Conversion After Mechanical Thrombectomy, Experience from a Large Comprehensive Stroke Center
BACKGROUND AND OBJECTIVES: Hemorrhagic conversion (HC) remains one of the most feared complications after mechanical thrombectomy (MT) for acute ischemic stroke and is associated with poor clinical outcomes. Evidence regarding predictors of HC after MT remains inconsistent. We sought to determine the incidence, predictors, and clinical impact of HC in a large contemporary cohort. METHODS: We conducted a retrospective analysis of a prospectively maintained database including consecutive patients who underwent MT for acute ischemic stroke between January 2016 and December 2024. Baseline clinical, radiographical, and procedural variables were collected. Outcomes were compared between patients with and without HC using 1:1 propensity score matching. Multivariable logistic regression was performed to identify independent predictors of HC. RESULTS: Among 896 patients undergoing MT, 267 (29.8%) experienced HC. After propensity score matching, HC remained associated with worse discharge neurological status (National Institutes of Health Stroke Scale 12.7 vs 9.6; P = .013), longer hospital length of stay (12.3 vs 9.9 days; P = .004), higher rates of decompressive craniectomy (9.4% vs 2.2%; P < .001), and increased likelihood of nonhome discharge (83% vs 71%; P < .001). In-hospital mortality was not significantly different after matching. On multivariable analysis, independent predictors of HC included higher admission National Institutes of Health Stroke Scale score (odds ratio [OR]: 1.04), diabetes mellitus (OR: 2.08), chronic kidney disease (OR: 1.76), and ≥3 thrombectomy passes (OR: 1.75). Increasing age (OR: 0.98), Black race (OR: 0.61), stent-retriever alone thrombectomy (OR: 0.53), and posterior circulation strokes (OR: 0.27) were all significantly associated with lower odds of HC. CONCLUSION: HC occurs in approximately one-third of patients undergoing MT and is independently associated with substantial neurological morbidity and healthcare utilization. Stroke severity, metabolic comorbidities, stroke location, and procedural complexity are key determinants of hemorrhagic risk. These findings support the need for enhanced risk stratification, and heightened postprocedural vigilance in high-risk patients.
- 21 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Incidence and Predictors of Hemorrhagic Conversion After Mechanical Thrombectomy, Experience from a Large Comprehensive Stroke Center
BACKGROUND AND OBJECTIVES: Hemorrhagic conversion (HC) remains one of the most feared complications after mechanical thrombectomy (MT) for acute ischemic stroke and is associated with poor clinical outcomes. Evidence regarding predictors of HC after MT remains inconsistent. We sought to determine the incidence, predictors, and clinical impact of HC in a large contemporary cohort. METHODS: We conducted a retrospective analysis of a prospectively maintained database including consecutive patients who underwent MT for acute ischemic stroke between January 2016 and December 2024. Baseline clinical, radiographical, and procedural variables were collected. Outcomes were compared between patients with and without HC using 1:1 propensity score matching. Multivariable logistic regression was performed to identify independent predictors of HC. RESULTS: Among 896 patients undergoing MT, 267 (29.8%) experienced HC. After propensity score matching, HC remained associated with worse discharge neurological status (National Institutes of Health Stroke Scale 12.7 vs 9.6; P = .013), longer hospital length of stay (12.3 vs 9.9 days; P = .004), higher rates of decompressive craniectomy (9.4% vs 2.2%; P < .001), and increased likelihood of nonhome discharge (83% vs 71%; P < .001). In-hospital mortality was not significantly different after matching. On multivariable analysis, independent predictors of HC included higher admission National Institutes of Health Stroke Scale score (odds ratio [OR]: 1.04), diabetes mellitus (OR: 2.08), chronic kidney disease (OR: 1.76), and ≥3 thrombectomy passes (OR: 1.75). Increasing age (OR: 0.98), Black race (OR: 0.61), stent-retriever alone thrombectomy (OR: 0.53), and posterior circulation strokes (OR: 0.27) were all significantly associated with lower odds of HC. CONCLUSION: HC occurs in approximately one-third of patients undergoing MT and is independently associated with substantial neurological morbidity and healthcare utilization. Stroke severity, metabolic comorbidities, stroke location, and procedural complexity are key determinants of hemorrhagic risk. These findings support the need for enhanced risk stratification, and heightened postprocedural vigilance in high-risk patients.
- 22 February 2022
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 215, 107183
Rescue stenting for acute ischemic stroke with refractory emergent large vessel occlusion in the modern thrombectomy era
- 22 February 2022
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 215, 107183
Rescue stenting for acute ischemic stroke with refractory emergent large vessel occlusion in the modern thrombectomy era
- 1 December 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (12) , 106117
Comparison of Anesthetic Agents Dexmedetomidine and Midazolam During Mechanical Thrombectomy
- 1 December 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (12) , 106117
Comparison of Anesthetic Agents Dexmedetomidine and Midazolam During Mechanical Thrombectomy
- Open Access
- 19 June 2020
- Published by Hindawi Limited in Anesthesiology Research and Practice
- Vol. 2020, 1-6
High Incidence of Burst Suppression during Propofol Sedation for Outpatient Colonoscopy: Lessons Learned from Neuromonitoring
Background. Although anesthesia providers may plan for moderate sedation, the depth of sedation is rarely quantified. Using processed electroencephalography (EEG) to assess the depth of sedation, this study investigates the incidence of general anesthesia with variable burst suppression in patients receiving propofol for outpatient colonoscopy. The lessons learned from neuromonitoring can then be used to guide institutional best sedation practice. Methods. This was a prospective observational study of 119 outpatients undergoing colonoscopy at Thomas Jefferson University Hospital (TJUH). Propofol was administered by CRNAs under anesthesiologists’ supervision. The Patient State Index (PSi™) generated by the Masimo SedLine® Brain Root Function monitor (Masimo Corp., Irvine, CA) was used to assess the depth of sedation. PSi data correlating to general anesthesia with variable burst suppression were confirmed by neuroelectrophysiologists’ interpretation of unprocessed EEG. Results. PSi values of <50 consistent with general anesthesia were attained in 118/119 (99.1%) patients. Of these patients, 33 (27.7%) attained PSi values <25 consistent with variable burst suppression. The 118 patients that reached PSi <50 spent a significantly greater percentage (53.1% vs. 42%) of their case at PSi levels 50 (). Mean total propofol dose was significantly correlated to patient PSi during periods of PSi <25 (, ). Conclusion. Although providers planned for moderate to deep sedation, processed EEG showed patients were under general anesthesia, often with burst suppression. Anesthesiologists and endoscopists may utilize processed EEG to recognize their institutional practice patterns of procedural sedation with propofol and improve upon it.- 19 June 2020
- Published by Hindawi Limited in Anesthesiology Research and Practice
- Vol. 2020, 1-6
Open AccessHigh Incidence of Burst Suppression during Propofol Sedation for Outpatient Colonoscopy: Lessons Learned from Neuromonitoring
Background. Although anesthesia providers may plan for moderate sedation, the depth of sedation is rarely quantified. Using processed electroencephalography (EEG) to assess the depth of sedation, this study investigates the incidence of general anesthesia with variable burst suppression in patients receiving propofol for outpatient colonoscopy. The lessons learned from neuromonitoring can then be used to guide institutional best sedation practice. Methods. This was a prospective observational study of 119 outpatients undergoing colonoscopy at Thomas Jefferson University Hospital (TJUH). Propofol was administered by CRNAs under anesthesiologists’ supervision. The Patient State Index (PSi™) generated by the Masimo SedLine® Brain Root Function monitor (Masimo Corp., Irvine, CA) was used to assess the depth of sedation. PSi data correlating to general anesthesia with variable burst suppression were confirmed by neuroelectrophysiologists’ interpretation of unprocessed EEG. Results. PSi values of <50 consistent with general anesthesia were attained in 118/119 (99.1%) patients. Of these patients, 33 (27.7%) attained PSi values <25 consistent with variable burst suppression. The 118 patients that reached PSi <50 spent a significantly greater percentage (53.1% vs. 42%) of their case at PSi levels 50 (). Mean total propofol dose was significantly correlated to patient PSi during periods of PSi <25 (, ). Conclusion. Although providers planned for moderate to deep sedation, processed EEG showed patients were under general anesthesia, often with burst suppression. Anesthesiologists and endoscopists may utilize processed EEG to recognize their institutional practice patterns of procedural sedation with propofol and improve upon it. - 14 August 2018
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 22 (10) , 69
A Contemporary Perspective on the Management of Post-Craniotomy Headache and Pain
This article discusses the etiology and management of post-craniotomy headache and pain. A review of available as well as investigatory treatment modalities is offered, followed by suggestions for optimal management of post-craniotomy headache.
- 14 August 2018
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 22 (10) , 69
A Contemporary Perspective on the Management of Post-Craniotomy Headache and Pain
This article discusses the etiology and management of post-craniotomy headache and pain. A review of available as well as investigatory treatment modalities is offered, followed by suggestions for optimal management of post-craniotomy headache.